GSGG — Destiny Alliance Biotechnology Income Statement
0.000.00%
Last trade - 00:00FinancialsMicro Cap
Annual income statement for Destiny Alliance Biotechnology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | |||||
| Gross Profit | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 0.023 | 0.015 | 0.011 | 0.016 | 0.024 |
| Operating Profit | -0.023 | -0.015 | -0.011 | -0.016 | -0.024 |
| Net Income Before Taxes | -0.023 | -0.015 | -0.011 | -0.016 | -0.024 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.023 | -0.015 | -0.011 | -0.016 | -0.024 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.023 | -0.015 | -0.011 | -0.016 | -0.024 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.023 | -0.015 | -0.011 | -0.016 | -0.024 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.001 | -0.001 | -0 | -0.001 | -0 |